Spots Global Cancer Trial Database for total lymphoid irradiation (tli)
Every month we try and update this database with for total lymphoid irradiation (tli) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD | NCT00185796 | Myeloproliferat... Blood Cancer Myelodysplastic... | Total Lymphoid ... Anti-Thymocyte ... | 49 Years - 75 Years | Stanford University | |
| Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML | NCT00568633 | Leukemia, Myelo... Leukemia Acute Myeloid L... | Allogeneic HSCT Anti-thymocyte ... Cyclosporine (C... Mycophenolate m... Total lymphoid ... Methylprednisol... Best standard c... | 50 Years - 75 Years | Stanford University | |
| Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation | NCT03734601 | Acute Myeloid L... Myelodysplastic... Myeloproliferat... Chronic Lymphoc... B-cell Lymphoma T-cell Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myelomo... | Total body irra... Anti-thymocyte ... Tacrolimus Mycophenolate m... Total lymphoid ... | 18 Years - | Stanford University | |
| Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders | NCT01392989 | Neural Tube Def... Anemia Leukemia, Myelo... Bone Marrow Tra... Myelodysplastic... Myeloproliferat... | CIK cells Cyclosporine Mycophenolate M... Thymoglobulin Total Lymphoid ... | 50 Years - | Stanford University | |
| Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies | NCT00185640 | Blood Cancer Leukemia | Cyclosporine Anti-thymocyte ... Mycophenolate m... Filgrastim Total Lymphoid ... | 50 Years - 70 Years | Stanford University | |
| TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD | NCT00185796 | Myeloproliferat... Blood Cancer Myelodysplastic... | Total Lymphoid ... Anti-Thymocyte ... | 49 Years - 75 Years | Stanford University | |
| Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation | NCT03734601 | Acute Myeloid L... Myelodysplastic... Myeloproliferat... Chronic Lymphoc... B-cell Lymphoma T-cell Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myelomo... | Total body irra... Anti-thymocyte ... Tacrolimus Mycophenolate m... Total lymphoid ... | 18 Years - | Stanford University | |
| Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies | NCT00185640 | Blood Cancer Leukemia | Cyclosporine Anti-thymocyte ... Mycophenolate m... Filgrastim Total Lymphoid ... | 50 Years - 70 Years | Stanford University | |
| Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML | NCT00568633 | Leukemia, Myelo... Leukemia Acute Myeloid L... | Allogeneic HSCT Anti-thymocyte ... Cyclosporine (C... Mycophenolate m... Total lymphoid ... Methylprednisol... Best standard c... | 50 Years - 75 Years | Stanford University | |
| Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation | NCT03734601 | Acute Myeloid L... Myelodysplastic... Myeloproliferat... Chronic Lymphoc... B-cell Lymphoma T-cell Lymphoma Non Hodgkin Lym... Hodgkin Lymphom... Chronic Myelomo... | Total body irra... Anti-thymocyte ... Tacrolimus Mycophenolate m... Total lymphoid ... | 18 Years - | Stanford University | |
| Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT | NCT00482053 | Lymphoma, B-cel... Lymphoma, Non-H... Diffuse Large B... Malignant Lymph... | Autologous hema... Allogeneic hema... Total lymphoid ... Rituximab Carmustine Etoposide Filgrastim Anti-thymocyte ... Cyclosporine Mycophenolate m... Cyclophosphamid... Acetaminophen Diphenhydramine Hydrocortisone Methylprednisol... | 18 Years - 70 Years | Stanford University | |
| Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders | NCT01392989 | Neural Tube Def... Anemia Leukemia, Myelo... Bone Marrow Tra... Myelodysplastic... Myeloproliferat... | CIK cells Cyclosporine Mycophenolate M... Thymoglobulin Total Lymphoid ... | 50 Years - | Stanford University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
